These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 31833625)
1. Critical evaluation of animal models of visceral pain for therapeutics development: A focus on irritable bowel syndrome. Johnson AC; Farmer AD; Ness TJ; Greenwood-Van Meerveld B Neurogastroenterol Motil; 2020 Apr; 32(4):e13776. PubMed ID: 31833625 [TBL] [Abstract][Full Text] [Related]
2. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial. Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287 [TBL] [Abstract][Full Text] [Related]
3. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Elsenbruch S Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682 [TBL] [Abstract][Full Text] [Related]
4. Stress and visceral pain: focusing on irritable bowel syndrome. Fukudo S Pain; 2013 Dec; 154 Suppl 1():S63-S70. PubMed ID: 24021863 [TBL] [Abstract][Full Text] [Related]
5. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. Moloney RD; Johnson AC; O'Mahony SM; Dinan TG; Greenwood-Van Meerveld B; Cryan JF CNS Neurosci Ther; 2016 Feb; 22(2):102-17. PubMed ID: 26662472 [TBL] [Abstract][Full Text] [Related]
6. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Keszthelyi D; Troost FJ; Masclee AA Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G141-54. PubMed ID: 22595988 [TBL] [Abstract][Full Text] [Related]
7. The Pharmacology of Visceral Pain. Johnson AC; Greenwood-Van Meerveld B Adv Pharmacol; 2016; 75():273-301. PubMed ID: 26920016 [TBL] [Abstract][Full Text] [Related]
8. Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Tillisch K; Labus J; Nam B; Bueller J; Smith S; Suyenobu B; Siffert J; McKelvy J; Naliboff B; Mayer E Aliment Pharmacol Ther; 2012 Feb; 35(3):360-7. PubMed ID: 22221140 [TBL] [Abstract][Full Text] [Related]
9. A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity. Traub RJ; Cao DY; Karpowicz J; Pandya S; Ji Y; Dorsey SG; Dessem D J Pain; 2014 Sep; 15(9):956-66. PubMed ID: 24981128 [TBL] [Abstract][Full Text] [Related]
10. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome. Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869 [TBL] [Abstract][Full Text] [Related]